A Canadian man accused of drug smuggling in China faced a new trial Monday after an upper court called for a harsher sentence in a case that could further strain ties between Beijing and Ottawa.
Robert Lloyd Schellenberg, who was originally sentenced to 15 years in prison and a 150,000 yuan (USD22,000) forfeiture, could now potentially face the death penalty under China's zero-tolerance drug laws.
His retrial in the northeast city of Dalian comes against the backdrop of the Chinese government's anger over the arrest in Canada of a top executive of telecom giant Huawei last month.
Chinese authorities have since detained two Canadian nationals -- a former diplomat and a business consultant -- on suspicion of endangering national security.
Schellenberg, who was reportedly detained in northeast Liaoning province in 2014, is accused of playing an important role in drug smuggling and of potentially being involved in international organised drug trafficking activities.
He was sentenced to 15 years in prison in November. His appeal backfired as a high court in Liaoning ruled in December that the sentence was too lenient given the severity of his crimes.
There has been little public information from the courts about Schellenberg's case, rights groups say, making it difficult to keep track of it. "It's clear that Chinese courts are not independent, and by systematic design, courts can be influenced by Communist Party officials," William Nee, China researcher at Amnesty International, told AFP.
Court retrials are rare, said Donald Clarke, a professor at George Washington University specialising in Chinese law, and even rarer are retrials calling for a harsher sentence.
"It is obvious... that Schellenberg's fate will have little to do with his actual guilt or innocence," Clarke added.
"If the Chinese government has an innocent explanation for all the unusual features of this case, I hope it will provide it," he added, "otherwise, I don't know how to understand this case other than as a simple threat."
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
